Glück Conviction Score™ ⓘ
GLTO
Damora Therapeutics, Inc.
ⓘ
Eingeschränkte Aussagekraft — erst 66 % der Signal-Gewichte sind mit Daten unterlegt.
Effektiv: Neutral
Niedrig
Bedeutung der Einstufung ⓘ
Insider
0,0
Keine Insider-Käufe
Institutionell
78,0
49 neu, 13 erhöht, 1383,4M $ netto
Aktivist
40,8
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,69% (Stand: 31.05.2026)
Score-Verlauf (90 Tage)
Farbzonen = Stärkestufen (Sehr schwach … Sehr stark). Exit-Score unter der Schwelle = Timing-Ausstieg. Komponenten per Legende einblenden.
Kursverlauf (12 Monate)
Technische Indikatoren
Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).
| Indikator | Signal | Gewicht | Wert | Detail | Beitrag |
|---|---|---|---|---|---|
| Kurs vs SMA50 | Bärisch | 10 % | 24.61 | -13.2 % vs SMA50 | |
| Kurs vs SMA200 | Bullisch | 15 % | 19.96 | +7.0 % vs SMA200 | |
| EMA20 vs EMA50 | Bärisch | 5 % | 22.93 | EMA50: 24.07 | |
| MACD-Histogramm | Bärisch | 10 % | -0.348 | Bearisch | |
| RSI(14) | Neutral | 10 % | 37.9 | Neutral (30–70) | |
| Stoch %K(14) | Neutral | 5 % | 35.1 | Neutral | |
| ADX(14)+DI | Neutral | 10 % | 23.2 | +DI: 7.5 / −DI: 23.2 | |
| Z-Score(60) | Bullisch | 5 % | -1.57 | Extrem überverkauft | |
| 52W-Position | Neutral | 5 % | 59.5 % | Hoch 34.14 / Tief 2.58 | |
| Bollinger(20,2σ) | Bullisch | 5 % | 19.9 % | Upper 26.98 / Mid 23.47 / Lower 19.96 | |
| LinReg-Slope(60) | Neutral | 10 % | -0.0241 | R²=0.05 / annualisiert -24.9 % |
Insider-Transaktionen (12 Monate) ⓘ
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-01-02 | Schambye Hans T. | Director, Officer, Chief Executive Officer | Open Market Sale | -700 | 21,38 | -14.966,00 | -330,5% | |
| 2026-01-02 | Winslow Garrett | Officer, General Counsel | Open Market Sale | -255 | 21,38 | -5.451,90 | -120,4% | |
| 2026-01-02 | Firmani Lori | Officer, Chief Financial Officer | Open Market Sale | -135 | 21,41 | -2.890,35 | -63,8% | |
| 2025-07-03 | Winslow Garrett | Officer, General Counsel | Open Market Sale | -260 | 3,39 | -881,40 | -19,5% | |
| 2025-07-03 | Firmani Lori | Officer, Interim CFO | Open Market Sale | -147 | 3,39 | -498,33 | -11,0% | |
| 2025-07-03 | Schambye Hans T. | Director, Officer, Chief Executive Officer | Open Market Sale | -735 | 3,38 | -2.484,30 | -54,9% |
Fondsaktivität (Vorquartalsvergleich) ⓘ
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| FMR LLC | 9.045.481 | 238.878 | 8.806.603 | 234.277.957 | Aufgestockt | +3686,7% | |
| Fairmount Funds Management LLC | 8.713.000 | 0 | 8.713.000 | 225.666.700 | Neu | +100,0% | |
| Avoro Capital Advisors LLC | 3.783.000 | 0 | 3.783.000 | 97.979.700 | Neu | +100,0% | |
| Venrock Adviser, LLC | 3.603.595 | 0 | 3.603.595 | 93.333.111 | Neu | +100,0% | |
| FCPM III SERVICES B.V. | 2.441.000 | 0 | 2.441.000 | 63.221.900 | Neu | +100,0% | |
| RA CAPITAL MANAGEMENT, L.P. | 2.399.310 | 0 | 2.399.310 | 62.142.129 | Neu | +100,0% | |
| JANUS HENDERSON GROUP PLC | 2.362.696 | 1.739 | 2.360.957 | 61.441.909 | Aufgestockt | +135765,2% | |
| VIKING GLOBAL INVESTORS LP | 2.311.082 | 0 | 2.311.082 | 59.857.024 | Neu | +100,0% | |
| Bellevue Group AG | 2.298.000 | 0 | 2.298.000 | 59.518.200 | Neu | +100,0% | |
| Remedium Capital Partners, LLC | 2.045.473 | 120.473 | 1.925.000 | 52.977.750 | Aufgestockt | +1597,9% | |
| Commodore Capital LP | 1.939.000 | 0 | 1.939.000 | 50.220.100 | Neu | +100,0% | |
| Cormorant Asset Management, LP | 1.525.000 | 0 | 1.525.000 | 39.497.500 | Neu | +100,0% | |
| BALYASNY ASSET MANAGEMENT L.P. | 1.448.000 | 0 | 1.448.000 | 37.503.200 | Neu | +100,0% | |
| a16z Capital Management, L.L.C. | 1.236.157 | 0 | 1.236.157 | 32.016.466 | Neu | +100,0% | |
| PERCEPTIVE ADVISORS LLC | 1.223.000 | 0 | 1.223.000 | 31.675.700 | Neu | +100,0% | |
| Point72 Asset Management, L.P. | 1.193.708 | 109.000 | 1.084.708 | 30.917.037 | Aufgestockt | +995,1% | |
| WELLINGTON MANAGEMENT GROUP LLP | 1.058.000 | 0 | 1.058.000 | 27.402.200 | Neu | +100,0% | |
| Siren, L.L.C. | 900.000 | 0 | 900.000 | 23.310.000 | Neu | +100,0% | |
| BRAIDWELL LP | 894.846 | 0 | 894.846 | 23.176.511 | Neu | +100,0% | |
| Vestal Point Capital, LP | 600.000 | 0 | 600.000 | 15.540.000 | Neu | +100,0% | |
| Blackstone Inc. | 503.522 | 0 | 503.522 | 13.041.220 | Neu | +100,0% | |
| MILLENNIUM MANAGEMENT LLC | 471.646 | 0 | 471.646 | 12.215.631 | Neu | +100,0% | |
| Affinity Asset Advisors, LLC | 450.000 | 0 | 450.000 | 11.655.000 | Neu | +100,0% | |
| Ikarian Capital, LLC | 335.710 | 285.710 | 50.000 | 8.694.889 | Aufgestockt | +17,5% | |
| Qube Research & Technologies Ltd | 282.436 | 0 | 282.436 | 7.315.092 | Neu | +100,0% | |
| ADAR1 Capital Management, LLC | 279.000 | 0 | 279.000 | 7.226.100 | Neu | +100,0% | |
| Nantahala Capital Management, LLC | 278.000 | 0 | 278.000 | 7.200.200 | Neu | +100,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 241.126 | 11.573 | 229.553 | 6.248.060 | Aufgestockt | +1983,5% | |
| BlackRock, Inc. | 222.437 | 7.520 | 214.917 | 5.761.119 | Aufgestockt | +2857,9% | |
| VANGUARD CAPITAL MANAGEMENT LLC | 201.847 | 0 | 201.847 | 5.227.837 | Neu | +100,0% | |
| STATE STREET CORP | 183.922 | 0 | 183.922 | 4.763.580 | Neu | +100,0% | |
| MARSHALL WACE, LLP | 169.818 | 0 | 169.818 | 4.398.286 | Neu | +100,0% | |
| UBS Group AG | 160.415 | 6.389 | 154.026 | 4.154.749 | Aufgestockt | +2410,8% | |
| Kalehua Capital Management LLC | 139.000 | 0 | 139.000 | 3.600.100 | Neu | +100,0% | |
| AMERIPRISE FINANCIAL INC | 117.675 | 0 | 117.675 | 3.047.782 | Neu | +100,0% | |
| BOOTHBAY FUND MANAGEMENT, LLC | 110.441 | 95.798 | 14.643 | 2.860.422 | Aufgestockt | +15,3% | |
| Jain Global LLC | 120.566 | 0 | 120.566 | 2.774.224 | Neu | +100,0% | |
| Seven Fleet Capital Management LP | 101.248 | 0 | 101.248 | 2.622.323 | Neu | +100,0% | |
| MORGAN STANLEY | 96.777 | 74.917 | 21.860 | 2.506.525 | Aufgestockt | +29,2% | |
| GOLDMAN SACHS GROUP INC | 88.336 | 0 | 88.336 | 2.287.902 | Neu | +100,0% | |
| Hudson Bay Capital Management LP | 76.338 | 0 | 76.338 | 1.977.154 | Neu | +100,0% | |
| Brevan Howard Capital Management LP | 55.232 | 0 | 55.232 | 1.430.509 | Neu | +100,0% | |
| NORTHERN TRUST CORP | 38.882 | 0 | 38.882 | 1.007.044 | Neu | +100,0% | |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 24.456 | 0 | 24.456 | 633.411 | Neu | +100,0% | |
| Squarepoint Ops LLC | 23.458 | 0 | 23.458 | 607.562 | Neu | +100,0% | |
| BARCLAYS PLC | 22.034 | 0 | 22.034 | 570.680 | Neu | +100,0% | |
| Catalyst Funds Management Pty Ltd | 17.293 | 0 | 17.293 | 447.889 | Neu | +100,0% | |
| VANGUARD GROUP INC | 18.247 | 0 | 18.247 | 419.863 | Neu | +100,0% | |
| BANK OF AMERICA CORP /DE/ | 15.647 | 1.228 | 14.419 | 405.257 | Aufgestockt | +1174,2% | |
| Sigma Planning Corp | 14.500 | 0 | 14.500 | 333.645 | Neu | +100,0% |
Top-Fondshalter (Stand: 31.03.2026) ⓘ
| Fonds | Anteile | Vorquartal (Stk) | Δ | Wert (USD) | Anteil (%) |
|---|---|---|---|---|---|
| FMR LLC | 9.045.481 | 238.878 | +3686,7% | 234.277.957 | 16,20 |
| Fairmount Funds Management LLC | 8.713.000 | 0 | +100,0% | 225.666.700 | 15,61 |
| Avoro Capital Advisors LLC | 3.783.000 | 0 | +100,0% | 97.979.700 | 6,78 |
| Venrock Adviser, LLC | 3.603.595 | 0 | +100,0% | 93.333.111 | 6,45 |
| FCPM III SERVICES B.V. | 2.441.000 | 0 | +100,0% | 63.221.900 | 4,37 |
| RA CAPITAL MANAGEMENT, L.P. | 2.399.310 | 0 | +100,0% | 62.142.129 | 4,30 |
| JANUS HENDERSON GROUP PLC | 2.362.696 | 1.739 | +135765,2% | 61.441.909 | 4,25 |
| VIKING GLOBAL INVESTORS LP | 2.311.082 | 0 | +100,0% | 59.857.024 | 4,14 |
| Bellevue Group AG | 2.298.000 | 0 | +100,0% | 59.518.200 | 4,12 |
| Remedium Capital Partners, LLC | 2.045.473 | 120.473 | +1597,9% | 52.977.750 | 3,66 |
| Commodore Capital LP | 1.939.000 | 0 | +100,0% | 50.220.100 | 3,47 |
| Cormorant Asset Management, LP | 1.525.000 | 0 | +100,0% | 39.497.500 | 2,73 |
| BALYASNY ASSET MANAGEMENT L.P. | 1.448.000 | 0 | +100,0% | 37.503.200 | 2,59 |
| a16z Capital Management, L.L.C. | 1.236.157 | 0 | +100,0% | 32.016.466 | 2,21 |
| PERCEPTIVE ADVISORS LLC | 1.223.000 | 0 | +100,0% | 31.675.700 | 2,19 |
| Point72 Asset Management, L.P. | 1.193.708 | 109.000 | +995,1% | 30.917.037 | 2,14 |
| WELLINGTON MANAGEMENT GROUP LLP | 1.058.000 | 0 | +100,0% | 27.402.200 | 1,89 |
| Siren, L.L.C. | 900.000 | 0 | +100,0% | 23.310.000 | 1,61 |
| BRAIDWELL LP | 894.846 | 0 | +100,0% | 23.176.511 | 1,60 |
| Vestal Point Capital, LP | 600.000 | 0 | +100,0% | 15.540.000 | 1,07 |
Halter-Trend (6 Quartale)
| Periode | Status | Halter | Anteile (Mio) | Wert (Mio $) |
|---|---|---|---|---|
| 31.03.2026 | ✓ | 65 | 59,7 | 1.545 |
| 31.12.2025 | ✓ | 18 | 1,2 | 64 |
| 30.09.2025 | ✓ | 12 | 0,2 | 1 |
| 30.06.2025 | ✓ | 9 | 0,1 | 0 |
| 31.03.2025 | ✓ | 11 | 0,2 | 0 |
| 31.12.2024 | ✓ | 10 | 0,1 | 1 |
Top 10 Neueinsteiger
| Fonds | Anteile | Wert (USD) ⓘ |
|---|---|---|
| JANUS HENDERSON GROUP PLC | 1.739 | 40.014.390 |
| Ikarian Capital, LLC | 285.710 | 6.574.187 |
| FMR LLC | 238.878 | 5.496.583 |
| Jain Global LLC | 120.566 | 2.774.224 |
| Point72 Asset Management, L.P. | 109.000 | 2.508.090 |
| BOOTHBAY FUND MANAGEMENT, LLC | 95.798 | 2.204.312 |
| MORGAN STANLEY | 74.917 | 1.723.840 |
| VANGUARD GROUP INC | 18.247 | 419.863 |
| Sigma Planning Corp | 14.500 | 333.645 |
| GEODE CAPITAL MANAGEMENT, LLC | 11.573 | 266.345 |
Top 10 Aufstocker
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| BlackRock, Inc. | 7.520 | 7.420 | +7420.0 % | 173.035 |
| UBS Group AG | 6.389 | 6.330 | +10728.8 % | 147.011 |
| CITIGROUP INC | 1.127 | 1.084 | +2520.9 % | 25.932 |
Top 10 Verkäufer
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| BANK OF AMERICA CORP /DE/ | 1.228 | -5.272 | -81.1 % | 28.256 |
| Tower Research Capital LLC (TRC) | 176 | -1.251 | -87.7 % | 4.050 |
| SBI Securities Co., Ltd. | 14 | -4 | -22.2 % | 322 |
Aktivisten & Großaktionäre (13D/13G) ⓘ
| Datum | Investor | Typ | Anteil | Aktien | Δ | Zweck |
|---|---|---|---|---|---|---|
| 15.05.2026 | Point72 Asset Management, L.P. | Passiv (13G/A) | 2,00 % | 1.193.708 | -4,30 pp | |
| 15.05.2026 | Point72 Capital Advisors, Inc. | Passiv (13G/A) | 2,00 % | 1.193.708 | -4,30 pp | |
| 15.05.2026 | Steven A. Cohen | Passiv (13G/A) | 2,00 % | 1.193.708 | -4,30 pp | |
| 15.05.2026 | Jain Global LLC | Passiv (13G/A) | Ausstieg | 0 | -7,50 pp | |
| 15.05.2026 | Jain Holdings LLC | Passiv (13G/A) | Ausstieg | 0 | -7,50 pp | |
| 15.05.2026 | Robert Jain | Passiv (13G/A) | Ausstieg | 0 | -7,50 pp | |
| 15.05.2026 | Behzad Aghazadeh | Passiv (13G) | 6,27 % | 3.783.000 | Neu | |
| 15.05.2026 | Avoro Capital Advisors LLC | Passiv (13G) | 6,27 % | 3.783.000 | Neu | |
| 24.04.2026 | Paramora Holding LLC | Passiv (13G/A) | 3,39 % | 2.045.473 | -4,11 pp | |
| 24.04.2026 | Paragon Therapeutics, Inc. | Passiv (13G/A) | 3,39 % | 2.045.473 | -4,11 pp | |
| 06.03.2026 | Ikarian Capital, LLC | Passiv (13G/A) | 0,60 % | 335.710 | -20,90 pp | |
| 06.03.2026 | Neil Shahrestani | Passiv (13G/A) | 0,60 % | 335.710 | -20,90 pp | |
| 17.02.2026 | Venrock Healthcare Capital Partners III, L.P. | Passiv (13G) | 6,00 % | 3.603.595 | Neu | |
| 17.02.2026 | VHCP Management EG, LLC | Passiv (13G) | 6,00 % | 3.603.595 | Neu | |
| 17.02.2026 | Bong Y. Koh | Passiv (13G) | 6,00 % | 3.603.595 | Neu | |
| 17.02.2026 | VHCP Management III, LLC | Passiv (13G) | 6,00 % | 3.603.595 | Neu | |
| 17.02.2026 | Venrock Healthcare Capital Partners EG, L.P. | Passiv (13G) | 6,00 % | 3.603.595 | Neu | |
| 17.02.2026 | VHCP Co-Investment Holdings III, LLC | Passiv (13G) | 6,00 % | 3.603.595 | Neu | |
| 17.02.2026 | Nimish Shah | Passiv (13G) | 6,00 % | 3.603.595 | Neu | |
| 17.02.2026 | Robert Jain | Passiv (13G) | 7,50 % | 120.566 | Neu | |
| 17.02.2026 | Jain Holdings LLC | Passiv (13G) | 7,50 % | 120.566 | Neu | |
| 17.02.2026 | Jain Global LLC | Passiv (13G) | 7,50 % | 120.566 | Neu | |
| 11.02.2026 | Tomas Kiselak | Aktivist (13D/A) | 19,99 % | 8.713.000 | 0,00 pp | Item 4 of the Statement is hereby amended and supplemented as follows: Conversion of Se… |
| 11.02.2026 | Peter Evan Harwin | Aktivist (13D/A) | 19,99 % | 8.713.000 | 0,00 pp | Item 4 of the Statement is hereby amended and supplemented as follows: Conversion of Se… |
| 11.02.2026 | Fairmount Healthcare Fund II L.P. | Aktivist (13D/A) | 13,32 % | 5.809.000 | -6,67 pp | Item 4 of the Statement is hereby amended and supplemented as follows: Conversion of Se… |
| 11.02.2026 | Fairmount Healthcare Co-Invest V L.P. | Aktivist (13D/A) | 6,66 % | 2.904.000 | -13,33 pp | Item 4 of the Statement is hereby amended and supplemented as follows: Conversion of Se… |
| 11.02.2026 | Fairmount Funds Management LLC | Aktivist (13D/A) | 19,99 % | 8.713.000 | 0,00 pp | Item 4 of the Statement is hereby amended and supplemented as follows: Conversion of Se… |
| 12.01.2026 | Paramora Holding LLC | Passiv (13G) | 7,50 % | 120.473 | Neu | |
| 12.01.2026 | Paragon Therapeutics, Inc. | Passiv (13G) | 7,50 % | 120.473 | Neu | |
| 05.12.2025 | Neil Shahrestani | Passiv (13G) | 21,50 % | 285.710 | Neu | |
| 05.12.2025 | Ikarian Capital, LLC | Passiv (13G) | 21,50 % | 285.710 | Neu | |
| 05.12.2025 | FMR LLC | Passiv (13G) | 15,00 % | 238.878 | Neu | |
| 05.12.2025 | Abigail P. Johnson | Passiv (13G) | 15,00 % | 238.878 | Neu | |
| 17.11.2025 | Fairmount Funds Management LLC | Aktivist (13D) | 19,99 % | 397.000 | Neu | The Reporting Persons own 19.99% of the Company in the aggregate, based upon the Company… |
| 17.11.2025 | Peter Evan Harwin | Aktivist (13D) | 19,99 % | 397.000 | Neu | The Reporting Persons own 19.99% of the Company in the aggregate, based upon the Company… |
| 17.11.2025 | Tomas Kiselak | Aktivist (13D) | 19,99 % | 397.000 | Neu | The Reporting Persons own 19.99% of the Company in the aggregate, based upon the Company… |
| 17.11.2025 | Fairmount Healthcare Fund II L.P. | Aktivist (13D) | 19,99 % | 397.000 | Neu | The Reporting Persons own 19.99% of the Company in the aggregate, based upon the Company… |
| 17.11.2025 | Fairmount Healthcare Co-Invest V L.P. | Aktivist (13D) | 19,99 % | 397.000 | Neu | The Reporting Persons own 19.99% of the Company in the aggregate, based upon the Company… |
| 13.11.2025 | Steven A. Cohen | Passiv (13G) | 6,30 % | 100.001 | Neu | |
| 13.11.2025 | Point72 Capital Advisors, Inc. | Passiv (13G) | 6,30 % | 100.001 | Neu |
Stammdaten
Galecto, Inc., ein Biotechnologie-Unternehmen in der klinischen Entwicklungsphase, entwickelt Moleküle zur Behandlung von Fibrose, Krebs, Entzündungen und anderen verwandten Erkrankungen. Der führende Produktkandidat des Unternehmens ist GB2064, das sich in der Phase IIa für die Behandlung von Myelofibrose befindet. Es entwickelt auch GB0139, einen inhalierten Galectin-3-Inhibitor, der sich in einer klinischen Phase-IIb-Studie für die Behandlung schwerer fibrotischer Lungenerkrankungen wie idiopathischer Lungenfibrose, einer lebensbedrohlichen fortschreitenden fibrotischen Lungenerkrankung, befindet; und GB1211, einen selektiven oralen Galectin-3-Inhibitor, der sich in der Phase IIa für die Krebsbehandlung sowie in der Phase Ib/IIa für Fibrose befindet. Galecto, Inc. wurde 2011 gegründet und hat seinen Sitz in Boston, Massachusetts.
Unternehmen & Branche
| Name | Damora Therapeutics, Inc. |
|---|---|
| Ticker | GLTO |
| CIK | 0001800315 |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | 36322Q107 |
|---|---|
| ISIN | US36322Q1076 |
| Typ | COM |
| Marktkapitalisierung | 33,4 Mio. USD |
| KGV (P/E) | 5,25 |
| Beta | 1,47 |
| Dividendenrendite | 0,00 % |
Bewertung
| KBV (P/B) | 0,14 vs. 16,32 (2021) ▼ |
|---|---|
| FCF-Rendite | -20,1 % vs. -2,7 % (2021) ▼ |
Qualität & Bilanz
| ROIC | -87,3 % vs. -43,8 % (2021) ▼ |
|---|
Basis: SEC-XBRL-Jahresabschluss bis 31.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2021. Kennzahlen erklärt →
Kennzahlen-Historie (5 Jahre) – Tabelle & Verlauf
| Kennzahl | 2021 | 2022 | 2023 | 2024 | 2025 | Verlauf |
|---|---|---|---|---|---|---|
| Bewertung | ||||||
| KBV (P/B) | 16,32 | 11,94 | 0,60 | 0,39 | 0,15 | |
| FCF-Rendite | -2,7 % | -5,8 % | -189,1 % | -304,1 % | -18,3 % | |
| Qualität & Bilanz | ||||||
| ROIC | -43,8 % | -98,5 % | -117,7 % | -134,8 % | -87,3 % | |
Basis: SEC-XBRL-Jahresabschlüsse, Multiples je Geschäftsjahr mit Marktkapitalisierung zum Bilanzstichtag (point-in-time).
Externe Quelle:
SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »
Finanzkennzahlen (SEC XBRL) ⓘ
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-03-31 | 10-Q | -27.783.000 | -0,62 | 535.442.000 | 511.603.000 | |
| 2025-12-31 | 10-K | -209.839.000 | 3,98 | 260.527.000 | 240.380.000 | |
| 2025-09-30 | 10-Q | -3.133.000 | -2,36 | 10.736.000 | 8.007.000 | |
| 2025-06-30 | 10-Q | -3.437.000 | -2,60 | 13.691.000 | 10.953.000 | |
| 2025-03-31 | 10-Q | -2.533.000 | -1,92 | 15.365.000 | 13.709.000 | |
| 2024-12-31 | 10-K | -21.439.000 | -18,53 | 17.132.000 | 15.831.000 | |
| 2024-09-30 | 10-Q | -3.883.000 | -3,39 | 23.376.000 | 20.935.000 | |
| 2024-06-30 | 10-Q | -5.338.000 | -0,20 | 27.297.000 | 23.588.000 | |
| 2024-03-31 | 10-Q | -5.477.000 | -0,20 | 32.477.000 | 28.159.000 | |
| 2023-12-31 | 10-K | -38.349.000 | -36,08 | 38.227.000 | 32.331.000 | |
| 2023-09-30 | 10-Q | -8.136.000 | -7,50 | 50.049.000 | 37.382.000 | |
| 2023-06-30 | 10-Q | -10.744.000 | -0,41 | 58.803.000 | 43.700.000 | |
| 2023-03-31 | 10-Q | -12.994.000 | -0,51 | 64.630.000 | 50.333.000 | |
| 2022-12-31 | 10-K | -61.624.000 | -2,43 | 73.188.000 | 61.753.000 | |
| 2022-09-30 | 10-Q | -13.730.000 | -0,54 | 82.025.000 | 72.727.000 | |
| 2022-06-30 | 10-Q | -16.887.000 | -0,67 | 92.858.000 | 85.065.000 | |
| 2022-03-31 | 10-Q | -16.938.000 | -0,67 | 108.930.000 | 101.314.000 | |
| 2021-12-31 | 10-K | -51.752.000 | -2,05 | 122.215.000 | 117.223.000 | |
| 2021-09-30 | 10-Q | -12.696.000 | -0,50 | 135.874.000 | 129.620.000 | |
| 2021-06-30 | 10-Q | -12.302.000 | 146.822.000 | 141.432.000 |
Quartalsergebnisse (Earnings) ⓘ
| Quartal | Stichtag | Verkündet | Umsatz | EPS |
|---|---|---|---|---|
| Q1 2026 | 31.03.2026 | 12.05.2026 | – | -0,62 |
| Q3 2025 | 30.09.2025 | 06.11.2025 | – | -2,36 |
| Q2 2025 | 30.06.2025 | 05.08.2025 | – | -2,60 |
| Q1 2025 | 31.03.2025 | 12.05.2026 | – | -1,92 |
| Q3 2024 | 30.09.2024 | 06.11.2025 | – | -3,39 |
| Q2 2024 | 30.06.2024 | 05.08.2025 | – | -4,92 |
| Q1 2024 | 31.03.2024 | 08.05.2025 | – | -5,05 |
| Q3 2023 | 30.09.2023 | 01.11.2024 | – | -7,50 |
| Q2 2023 | 30.06.2023 | 12.08.2024 | – | -0,41 |
Einreichungs-Historie (10-K / 10-Q)
SEC-Einreichungs-Historie der Quartalsberichte (10-Q) und Jahresberichte
(10-K) der letzten sechs Jahre. Die Spalte „Verzögerung" zeigt die
Tage zwischen Berichtsstichtag und tatsächlicher Einreichung.
Suffix /A kennzeichnet nachträgliche Berichtigungen.
| Eingereicht | Form | Berichtsperiode | Verzögerung | |
|---|---|---|---|---|
| 12.05.2026 | 10-Q | – | – | SEC » |
| 19.03.2026 | 10-K | 31.12.2025 | 78 Tage | SEC » |
| 06.11.2025 | 10-Q | 30.09.2025 | 37 Tage | SEC » |
| 05.08.2025 | 10-Q | 30.06.2025 | 36 Tage | SEC » |
| 08.05.2025 | 10-Q | 31.03.2025 | 38 Tage | SEC » |
| 19.03.2025 | 10-K | 31.12.2024 | 78 Tage | SEC » |
| 01.11.2024 | 10-Q | 30.09.2024 | 32 Tage | SEC » |
| 12.08.2024 | 10-Q | 30.06.2024 | 43 Tage | SEC » |
| 29.04.2024 | 10-Q | 31.03.2024 | 29 Tage | SEC » |
| 08.03.2024 | 10-K | 31.12.2023 | 68 Tage | SEC » |
| 06.11.2023 | 10-Q | 30.09.2023 | 37 Tage | SEC » |
| 31.07.2023 | 10-Q | 30.06.2023 | 31 Tage | SEC » |
| 28.04.2023 | 10-Q | 31.03.2023 | 28 Tage | SEC » |
| 09.03.2023 | 10-K | 31.12.2022 | 68 Tage | SEC » |
| 08.11.2022 | 10-Q | 30.09.2022 | 39 Tage | SEC » |
| 29.07.2022 | 10-Q | 30.06.2022 | 29 Tage | SEC » |
| 29.04.2022 | 10-Q | 31.03.2022 | 29 Tage | SEC » |
| 17.02.2022 | 10-K | 31.12.2021 | 48 Tage | SEC » |
| 04.11.2021 | 10-Q | 30.09.2021 | 35 Tage | SEC » |
| 05.08.2021 | 10-Q | 30.06.2021 | 36 Tage | SEC » |
| 04.05.2021 | 10-Q | 31.03.2021 | 34 Tage | SEC » |
| 29.03.2021 | 10-K | 31.12.2020 | 88 Tage | SEC » |
| 11.12.2020 | 10-Q | 30.09.2020 | 72 Tage | SEC » |
Kritische 8-K Meldungen ⓘ
WARNUNG: Kritische 8-K-Meldung(en)
HOCH Abgang Schlüsselpersonen (04.05.2026)
HOCH Abgang Schlüsselpersonen (23.03.2026)
HOCH Abgang Schlüsselpersonen (04.05.2026)
HOCH Abgang Schlüsselpersonen (23.03.2026)
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 04.05.2026 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 23.03.2026 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 06.01.2026 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ereto, which is incorporated herein by reference. Item 5.02 – Departure of Directors or Certain Officers; Election of… |
| 15.10.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Exchange Act. ☐ Item 5.02 – Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain… |
| 07.10.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | of the Securities Act. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of… |
| 09.02.2022 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 06.07.2021 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 – Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |